Scotiabank raised the firm’s price target on Welltower (WELL) to $182 from $181 and keeps an Outperform rating on the shares. Welltower is buying real estate that sits well-positioned in hard-to-build Canadian markets, the analyst tells investors in a research note. Recent broker checks also point to Welltower considering a sale of a sizeable medical office building portfolio, which the firm would view positively if executed at a low-6% cap rate to reinvest into the faster-growth Seniors Housing segment.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WELL: